ici 204,219 has been researched along with Psoriasis in 2 studies
zafirlukast: a leukotriene D4 receptor antagonist
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zemtsov, A | 1 |
| Bucchino, S | 1 |
| McDowell, MR | 1 |
| Santais, MC | 1 |
| Callens, E | 1 |
| Djebbar, R | 1 |
| Ruff, F | 1 |
1 review available for ici 204,219 and Psoriasis
| Article | Year |
|---|---|
[Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class].
Topics: Acetophenones; Adult; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthr | 1998 |
1 other study available for ici 204,219 and Psoriasis
| Article | Year |
|---|---|
Potential use of leukotriene inhibitors in treatment of psoriasis.
Topics: Administration, Oral; Adult; Aged; Female; Humans; Indoles; Leukotriene Antagonists; Middle Aged; Ph | 2003 |